Sitio oficial del Grupo Punta Cana de Coordinadores de Trasplantes


 

Actividades

ESOT Glasgow


Escucha el texto Escucha el texto

Entre el 4 al 7 de septiembre de 2011 en Glasgow, Reino Unido.

Publicado el: 27 de mayo de 2011 a las 09:16

ESOT Glasgow

4 al 7 de septiembre de 2011

Sitio web del evento

ESOT 2011 PRELIMINARY PROGRAMME

Sunday 4 September, 2011

Programa científico del evento:

18:10 Opening & Welcome Address ESOT 2011

ESOT 2011 Co-chairs: John Forsythe, Edinburgh, United Kingdom;

Alan Jardine, Glasgow, United Kingdom

18:30 – 19:10 PLENARY SESSION 1

Controlling the immune response

Chairs: John Forsythe, Edinburgh, United Kingdom;

Alan Jardine, Glasgow, United Kingdom

18:30 The challenge of immune tolerance in transplant patients

Lucienne Chatenoud, Paris, France

18:50 Immunosuppressive agents, how to make a choice

Flavio Vincenti, San Francisco, United States

19:10 A meeting with a difference – how you contribute and benefit

Keith Rigg, Nottingham, United Kingdom

19:20 – 20:30 POSTER OPENING & WELCOME EVENT

19:20 – 20:30 MINI ORAL SESSIONS

19:20 – 20:30 RAPID ORAL SESSIONS

Monday 5 September, 2011

08:00 – 09:00 FULL ORAL SESSIONS

08:00 – 09:00 CLINICAL CASES DISCUSSION GROUPS

(selected from abstract submission)

09:00 – 10:30 STATE OF THE ART 1

Improving Patient Outcomes after Liver Transplantation

Chairs: Paolo Muiesan, Birmingham, United Kingdom;

09:00 Minimising immunosuppression in liver transplantation – evidence and prospects for personalised medicine

Alberto Sanchez-Fueyo, Barcelona, Spain (TBC)

09:20 Minimising renal dysfunction in liver transplantation – preventative strategies – how, with what and when

John Lake, Minneapolis, United States

09:40 Minimising cardiovascular risk factors in liver transplantation

– evidence and prospects

Andrew Burroughs, London, United Kingdom

10:00 Quality of Life and Compliance after Liver Transplantation

Patrizia Burra, Padova, Italy

10:20 – 10:30 Q & A

09:00 – 10:30 STATE OF THE ART 2

Cells that rule rejection and tolerance

Chairs: Manuela Battaglia, Milan, Italy;

Thomas Wekerle, Vienna, Austria

09:00 What can zebra fish tell us about key inflammatory events that

drive transplant rejection?

Maggie Dallman, London, United Kingdom

09:20 What cells are actually causing rejection?

Frans Claas, Leiden, The Netherlands

09:40 Regulatory T cells

Matthias Edinger, Regensburg, Germany

10:00 Regulatory B cells

Claudia Mauri, University College London, United Kingdom

10:20 – 10:30 Q & A

09:00 – 10:30 STATE OF THE ART 3 Joint Session ESOT & AST

Challenges in kidney transplantation

Chairs: Josep Campistol, Barcelona,Spain;

Alan Jardine, Glasgow, United Kingdom

09:00 Making the graft last longer

Robert Gaston, Birmigham, United States

09:20 When to use antibody removal strategies

Gunnar Tyden, Stockholm, Sweden

09:40 How to manage BK nephropathy

Rachel Hilton, London, United Kingdom

10:00 Non HLA antibody rejection

Peter Heeger, New York, United States

10:20 – 10:30 Q & A

11:00 – 12:50 FULL ORAL SESSIONS

13:00 – 14:00 RAPID ORAL SESSIONS & POSTER VIEWING

14:00 – 15:30 PLENARY SESSION 2

Making the most of the marginal organ

Chairs: Peter Friend, Oxford, United Kingdom;

Rutger Ploeg, Groningen, The Netherlands

14:00 The marginal organ - information and consent

James Neuberger, Birmigham, United Kingdom

14:20 The science of marginal organs

Jacques Pirenne, Leuven, Belgium

14:40 Putting science into practice: lung

Stig Steen, Lund, Sweden

15:00 Putting science into practice: liver

Joseph Tector, Indianapolis, United States

15:20 – 15:30 Q & A

16:00 – 17:00 NEW CONTROVERSIES 1

The treatment for chronic antibody mediated rejection is…..

Chairs: Anthony Warrens, London, United Kingdom;

Discussants: David Taube, London, United Kingdom

Christophe Legendre, Paris, France

16:40 - 17:00 Discussion

16:00 – 17:00 NEW CONTROVERSIES 2

The solution to the organ shortage is…..

Chairs:Willem Weimar, Rotterdam, The Netherlands;

Beatriz Dominguez-Gil, Madrid, Spain

16:00 Living donation

Arthur Matas, Minneapolis, United States

16:20 Marginal organs

Björn Nashan, Hamburg, Germany

16:40 - 17:00 Discussion

16:00 – 17:00 RAPID ORAL SESSIONS

16:00 – 17:00 MINI ORAL SESSIONS

16:00 – 18:00 FULL ORAL SESSIONS

Tuesday 6 September, 2011

08:00 – 09:00 FULL ORAL SESSIONS

08:00 – 09:00 CLINICAL CASES DISCUSSION GROUPS

(selected from abstract submission)

09:00 – 10:30 STATE OF THE ART 4

Diverse Populations

Chairs: Willem Weimar, Rotterdam, The Netherlands;

Gabriel Danovitch, Los Angeles, United States

09:00 Organ donation and transplantation: realities for minority ethnic groups

Gurch Randhawa, Luton, United Kingdom

09:20 Social factors and the availability of living kidney donation in

diverse populations

Joke Roodnat, Rotterdam, The Netherlands

09:40 Increasing the deceased organ donation rate among immigrant populations

Teresa Pont-Castellana, Barcelona, Spain

10:00 – 10:30 Q & A

09:00 – 10:30 STATE OF THE ART 5

The pancreas/islet donor: new developments

Chairs:Thierry Berney, Geneva, Switzerland;

Johann Pratschke, Innsbruck, Austria

09:00 DCD donors in whole pancreas transplantation

Peter Friend, Oxford, United Kingdom

09:20 Expanding the donor pool for whole pancreas transplantation

Hans Schlitt, Regensburg, Germany

09:40 Donor strategies to improve the outcome of islet transplantation

Bernhard Hering, Minneapolis, United States

10:00 Solitary whole pancreas versus islets: is it time for a clinical trial?

François Pattou, Lille, France

10:20 – 10:30 Q & A

09:00 – 10:30 STATE OF THE ART 6

Biomarkers of Tolerance/Rejection

Chairs: Lorna Marson, Edinburgh, United Kingdom;

Kathryn Wood, Oxford, United Kingdom

09:00 Omics, heat-maps and gene expression profiles:

What they are and what they mean

Minnie Sarwal, United States

09:20 In vitro assays as biomarkers for rejection and engraftment

Maria Hernandez­Fuentes, London, United Kingdom

09:40 Biomarkers: How to model in vivo cellular responses

Alberto Sanchez-Fueyo, Barcelona, Spain

10:00 Biomarkers: New techniques in the laboratory

Robert Lechler, London, United Kingdom

10:20 – 10:30 Q & A

11:00 – 12:50 FULL ORAL SESSIONS

13:00 – 14:00 RAPID ORAL SESSIONS

14:00 – 15:30 PLENARY SESSION 3

Transplantation tomorrow

Chairs: Jean-Micheal Dubernard, Lyon, France;

Robert Gaston, Birmigham, United States

14:00 Composite Tissue Transplantation

Stefan Schneeberger, Innsbruck, Austria

14:20 Tissue Engineering - beyond the trachea

Doris Taylor, Minneapolis, United States

14:40 Minimising the immune response – what is the current science?

Carla Baan, Rotterdam, The Netherlands

15:00 Xenotransplantation - still the future?

Emanuele Cozzi, Padova, Italy

16:00 – 17:00 NEW CONTROVERSIES 3

The big advances in transplantation have come from….

Chairs: Keith Rigg, Nottingham, United Kingdom;

Björn Nashan, Hamburg, Germany

16:00 The randomized controlled trial

Henrik Ekberg, Malmo, Sweden

16:20 Unrandomized innovation

16:40 - 17:00 Discussion

16:00 – 17:00 NEW CONTROVERSIES 4

Organ allocation should be based on…

Chairs: Chris Watson, Cambridge, United Kingdom;

Jan Lerut, Leuven, Belgium

16:00 Fairness / equity

Assya Pascalev, Sofia, Bulgaria

16:20 Transplant benefit

Alexander Gimson, Cambridge, United Kingdom

16:40 - 17:00 Discussion

16:00 – 17:00 RAPID ORAL SESSIONS

16:00 – 17:00 MINI ORAL SESSIONS

16:00 – 17:00 FULL ORAL SESSIONS

Wednesday 7 September, 2011

08:00 – 09:00 FULL ORAL SESSIONS

08:00 – 09:00 CLINICAL CASES DISCUSSION GROUPS

(selected from abstract submission)

09:00 – 10:30 STATE OF THE ART 7

Thoracic transplantation from non-heart beating donors

Chairs:Nicholas R. Banner, London, United Kingdom;

Dirk Van Raemdonck, Leuven, Belgium

09:00 NHBD lung transplantation: how far can we go?

Michiel Erasmus, Groningen, The Netherlands

09:20 NHBD heart transplantation: fiction or reality?

Steve Large, Cambridge, United Kingdom

09:40 Machine perfusion for lung transplantation

Karen Redmond, London United Kingdom

10:00 Machine perfusion for heart transplantation

Olivier Van Caenegem, Leuven, Belgium

10:20 Q & A

09:00 – 10:30 STATE OF THE ART 8

Optimizing organ quality

Chairs: Benoit Barrou, Paris, France;

Robert Porte, Groningen, The Netherlands

09:00 Ischaemic preconditioning

Pierre Clavien, Zurich, Switzerland

09:20 Normothermic recirculation

Juan Carlos García-Valdecasas, Barcelona, Spain

09:40 Modifying ischemia reperfusion injury

Stefan Tullius, Boston, United States

10:00 Machine liver perfusion

Rutger Ploeg, Groningen, The Netherlands

10:20 Q & A

09:00 – 10:30 STATE OF THE ART 9 Joint ESOT EFI BSHI Session

Histocompatibility & Immunogenetics

09:00 Current techniques for Clinical H&I; testing

Taylor Craig, Cambridge, United Kingdom

09:20 H&I; testing to support patient care

Robert Bray, Atlanta, United States

09:40 H&I; testing and outcome in transplantation – CTS data

Gerhard Opelz, Heidelberg, Germany

10:00 Future developments for H&I; support of clinical transplantation

Frans Claas, Leiden, The Netherlands

10:20 Q & A

11:00 – 13:30 PLENARY SESSION 4 What's hot - What's new

Presidential - Best Abstracts presentation -Awards Ceremony

11:00 Presidential address

ESOT President elect

11:15 Honorary Membership celebration:

Kathryn Wood, past-Councilor of ESOT, past-President of TTS,

introduces

Honorary Member Leslie Brent, United Kingdom, United Kingdom

Jan Lerut, past-President of ESOT, introduces

Honorary Member Göran Klintmalm, Dallas, United States

11:35 What’s hot, what’s new in clinical transplantation?

Steve Wigmore, Edinburgh, United Kingdom

11:55 What’s hot, what’s new in basic science?

Olivier Thaunat, Lyon, France

12:15 – 13:05 Best Oral presentations – Biotest Clinical and Basic Science Awards

13.05 – 13.30 Awards & Grants Ceremony

Closing


Tweet

      Enviarme una copia del correo

Busqueda




Calendario
Agenda 2012 
marzo
DoLuMaMiJuViSá
123
45678910
11121314151617
18192021222324
25262728293031

Contacto

Correo electrónico: grupopuntacanapc@gmail.com
www.grupopuntacana.org
Rafael Pastoriza 1322
Montevideo
Contáctanos

Recomendados

Sitio oficial del Grupo Punta Cana de Coordinadores de Trasplantes

Registro Iberoamericano de Donacion y Trasplante

Esta página fue generada en 0.1214180 segundos (3)